EDIT: A New International Multicentre Programme to Develop and Evaluate Batteries of In Vitro Tests for Acute and Chronic Systemic Toxicity

Abstract

The Multicenter Evaluation of In Vitro Cytotoxicity (MEIC) programme provided a battery of three basal cytotoxicity tests with a good (R² ⁼ 0.77) prediction of human acute lethal blood concentrations. The predictive power of this battery would be considerably improved by the addition of new supplementary in vitro tests. The development of these new tests will be facilitated by a close coupling of test development to evaluation. The Cytotoxicology Laboratory, Uppsala (CTLU), is therefore inviting all interested in vitro toxicologists to take part in the Evaluation-guided Development of In Vitro Toxicity and Toxicokinetic Tests (EDIT). All EDIT activities (subprojects) will be designed on a case-by-case basis, but will follow a common pattern. The CTLU will use the accumulated MEIC/EDIT data, and its experience from the previous MEIC evaluation, to suggest priority areas, i.e. the need for certain in vitro toxicity data/tests as supplements to existing in vitro models/batteries on human systemic toxicity. Detailed research programmes corresponding to these areas will be published on the Internet. The CTLU will also try to raise funds for some projects and will coordinate multilaboratory studies. Interested laboratories developing or already using priority tests are encouraged to join the subprojects and to test specific sets of substances (usually sets of MEIC reference chemicals) in their new assays. The CTLU will provide adequate human reference data and will also evaluate results as single components of complex models, together with the laboratory conducting the test. At present, ten priority areas have been identified: a) repeat dose toxicity in vitro; b) urgent mechanistic information from in vitro studies of protein denaturation, morphology of cell injury, differential toxicity between various rapidly measured end-points (10–60 minutes) and 24-hour cytotoxicity, toxicity to aerobic cells, and discrimination between rapid and slow cytotoxic mechanisms; c) in vitro tests on vitally important, specific receptor toxicity in humans; d) excitatory cytotoxicity; e) reversibility of cell toxicity; f) in vitro tests on passage across the blood–brain barrier; g) in vitro tests on absorption in the gut; h) protein binding in vitro; i) in vitro tests on distribution volumes (Vd); and j) in vitro tests on bio-transformation to more-toxic metabolites (hepatocytes plus target cells). This paper gives a short presentation of the rationale for each subproject and reports on ongoing activities.

Keywords

acute poisoning alternatives basal cytotoxicity cell morphology chronic toxicity cell toxicity evaluation human toxicity kinetics lethal concentration lethal dose test development toxicity testing toxicology

Get full access to this article

View all access options for this article.

References

Bondesson

, Ekwall

, Hellberg

, Romert

, Stenberg

, & Walum

(1989). MEIC — A new international multicenter project to evaluate the relevance to human toxicity of in vitro cytotoxicity tests. Cell Biology and Toxicology 5, 331–347.

Ekwall

, Bondesson

, Castell

J.V.

, Gómez-Lechón

M.J.

, Hellberg

, Högberg

, Jover

, Ponsoda

, Romert

, Stenberg

, & Walum

(1989). Cytotoxicity evaluation of the first ten MEIC chemicals: acute lethal toxicity in man predicted by cytotoxicity in five cellular assays and by oral LD50 tests in rodents. ATLA 17, 83–100.

Ekwall

(1998). MEIC evaluation of acute systemic toxicity. Part VI. Prediction of human toxicity by rodent LD50 values and results from 61 in vitro tests. ATLA 26, Suppl. 2, 617–658.

Ekwall

(1999). Overview of the final MEIC results. II. The in vitro/in vivo evaluation, including a selection of a practical battery of cell tests for prediction of acute lethal blood concentrations in humans. Toxicology in Vitro, in press.

Ekwall

, Ekwall

, & Sjöstrom

(1999). MEIC evaluation of acute systemic toxicity. Part VIII. Multivariate PLS evaluation, including the selection of a battery of cell line tests with a good prediction of human acute lethal blood concentrations for 50 chemicals. ATLA, in press.

Walum

, Forsby

, Clemedson

, & Ekwall

(1996). Dynamic qualities of validation and the evolution of new in vitro toxicological tests. ATLA 24, 333–338.

Walum

, Clemedson

, & Ekwall

(1994). Principles for the validation of in vitro toxicology test methods. Toxicology in Vitro 8, 807–812.

Ekwall

, Barile

F.A.

, Dierickx

, Gómez-Lechón

M.J.

, Kunimoto

, Sawyer

, & Shrivastava

(1998). Development and evaluation of in vitro tests of repeated dosage toxicity. Web site http://www.ctlu.se. När, Sweden: CTLU.

Shrivastava

, John

, Rispat

, Chevalier

, & Massingham

(1991). Can the in vivo maximum tolerated dose be predicted using in vitro techniques? A working hypothesis. ATLA 19, 393–402.

10.

Dierickx

, & Ekwall

(1992). Long-term cytotoxicity testing of the first twenty MEIC chemicals by the determination of the protein content in human embryonic lung cells. ATLA 20, 285–289.

11.

Dierickx

P.J.

, & Ekwall

(1993). Long-term cytotoxicity testing of the MEIC chemicals 21–50 by the determination of the protein content in human embryonic lung cells. AATEX 2, 33–36.

12.

Ekwall

(1980). Toxicity to HeLa cells of 205 drugs as determined by the metabolic inhibition test supplemented by microscopy. Toxicology 17, 273–295

13.

Ekwall

(1980). Preliminary studies on the validity of in vitro measurement of drug toxicity using HeLa cells. II. Drug toxicity in the MIT-24 system compared with mouse and human lethal dosage of 52 drugs. Toxicology Letters 5, 309–317.

14.

Clemedson

(1998). MEIC evaluation of acute systemic toxicity. Part IV. In vitro results from 67 toxicity assays used to test reference chemicals 31–50 and a comparative cytotoxicity analysis. ATLA 26, Suppl. 1, 131–183.

15.

Ekwall

(1983). Screening of toxic compounds in mammalian cell cultures. In Annals of the New York Academy of Sciences, Vol. 407, Cellular Systems for Toxicity Testing (ed. Williams

G.M.

, Dunkel

V.C.

, & Ray

V.A.

), pp. 64–77. New York, USA: The New York Academy of Sciences.

16.

Zucco

(1997). Closing the gap between cell death and in vitro toxicity testing. In Animal Alternatives, Welfare and Ethics (ed. van Zutphen

L.F.M.

, & Balls

), pp. 541–548. Amsterdam, The Netherlands: Elsevier.

17.

Clemedson

(1996). MEIC evaluation of acute systemic toxicity. Part II. In vitro results from 68 toxicity assays used to test the first 30 reference chemicals and a comparative cytotoxicity analysis. ATLA 24, Suppl. 1, 273–311.

18.

Clemedson

(1998). MEIC evaluation of acute systemic toxicity. Part III. In vitro results from 16 additional methods used to test the first 30 reference chemicals and a comparative cytotoxicity analysis. ATLA 26, Suppl. 1, 93–129.

19.

Rat

, Osseni

, Christen

M.O.

, Thevenin

, Warnet

J-M.

, & Adolphe

(1997). Microtitration fluorometric assays on living cells: new tools for screening in cell pharmacotoxicology. In Animal Alternatives, Welfare and Ethics (ed. van Zutphen

L.F.M.

, & Balls

), pp. 813–823. Amsterdam, The Netherlands: Elsevier.

20.

Walum

, Stenberg

, & Jenssen

(1990). Understanding Cell Toxicology: Principles and Practice, 206 pp. New York, USA: Ellis Horwood.

21.

Ekwall

, Clemedson

, Crafoord

, Ekwall

, Hallander

, Walum

, & Bondesson

(1998). MEIC evaluation of acute systemic toxicity. Part V. Rodent and human toxicity data for the 50 reference chemicals. ATLA 26, Suppl. 2, 571–616.

22.

Ekwall

, & Acosta

(1982). In vitro comparative toxicity of selected drugs and chemicals in HeLa cells, Chang liver cells, and rat hepatocytes. Drug and Chemical Toxicology 5, 219–231.

23.

Ekwall

, & Ekwall

(1988). Comments on the use of diverse cell systems in toxicity testing. ATLA 15, 193–200.

24.

Imai

, Nakamura

, Takoka

, & Nakamura

(1988). Cytotoxicity of metal ions from the viewpoint of cell recovery. Journal of Dental Technology 16, 980–983.

25.

Imai

, Nakamura

, Matsumoto

, & Kokita

(1992). Cytotoxicity test using cell recovery test method. Medicine and Biology 125, 109–112.

26.

Clemedson

, & Ekwall

(1999). Overview of the final MEIC results. I. The in vitro/in vitro evaluation. Toxicology in Vitro, in press.

27.

Clemedson (1999). MEIC evaluation of acute systemic toxicity. Part VII. Prediction of human toxicity by results from testing of the first 30 reference chemicals with 27 further in vitro assays. ATLA, in press.

28.

Walker

, & Coleman

(1995). The blood–brain barrier: in vitro methods and toxicological applications. Toxicology in Vitro 9, 191–204.

29.

Garberg

(1998). In vitro models of the blood–brain barrier. ATLA 26, 821–847.

30.

Stewart

B.H.

, Chan

O.H.

, Jezyk

, & Fleisher

(1997). Discrimination between drug candidates using models for evaluation of intestinal absorption. Advanced Drug Delivery Reviews 23, 27–45.

31.

Lee

C-P.

, de Vrueh

R.L.A.

, & Smith

P.L.

(1997). Selection of development candidates based on in vitro permeability measurements. Advanced Drug Delivery Reviews 23, 47–62.

32.

Ekwall

(1997). The EDIT programme. Web site http://www.ctlu.se. När, Sweden: CTLU.

33.

Ekwall

(1982). Vacuolisation of HeLa cells in response to cytotoxic concentrations of drugs and chemicals. In The Abstract Book of the 2nd International Workshop on the Application of Tissue Culture in Toxicology, June 2–4 (ed. Heilbronn

, & Walum

). Stockholm, Sweden.

34.

Ekwall

(1982). Cytoplasmic blebbing of HeLa cells in response to toxic concentrations of drugs and chemicals. In Vitro 18, 3, Part II, Abstract 63.